42672 Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices 

RECORD ACCESS PROCEDURES: 

An individual seeking access to 

records about him or her in this system 

of records should submit an access 

request to the System Manager 

identified in the ‘‘System Manager’’ 

section of this SORN, and must follow 

the access procedures contained in the 

HHS Privacy Act regulations, 45 CFR 

part 5b (currently located in section 

5b.5). The individual’s right of access 

under the Privacy Act will be subject to 

the exemptions promulgated for this 

system of records. Records compiled in 

reasonable anticipation of a civil action 

or proceeding are excluded from the 

Privacy Act access requirement in all 

systems of records as provided in 5 

U.S.C. 552a(d)(5). 

CONTESTING RECORD PROCEDURES: 

An individual seeking to amend a 

record about him or her in this system 

of records should submit an amendment 

request to the System Manager indicated 

in the ‘‘System Manager’’ section of this 

SORN, and must follow the correction/ 

amendment procedures contained in the 

HHS Privacy Act regulations, 45 CFR 

part 5b (currently located in section 

5b.7). The individual’s right of 

amendment will be subject to the 

exemptions promulgated for this system 

of records. 

NOTIFICATION PROCEDURES: 

An individual who wishes to know if 

this system contains records about him 

or her should submit a notification 

request to the System Manager indicated 

in the ‘‘System Manager’’ section of this 

SORN, and must follow the notification 

procedures contained in the HHS 

Privacy Act regulations, 45 CFR part 5b 

(currently located in section 5b.5). The 

individual’s right to notification will be 

subject to the exemptions promulgated 

for this system of records. 

EXEMPTIONS PROMULGATED FOR THE SYSTEM: 

Upon completion of the Department’s 

pending rulemaking (i.e., when a Final 

Rule has been published in the Federal 

Register and has become effective based 

on the Notice of Proposed Rulemaking 

published elsewhere in today’s Federal 

Register), this system of records will be 

exempt from access and other 

requirements of the Privacy Act, as 

follows: 

• Material compiled in this system of 

records that is from another system of 

records in which such material was 

exempted from access and other 

requirements of the Privacy Act (the 

Act) based on 5 U.S.C. 552a(j)(2) will be 

exempt in this system of records on the 

same basis (5 U.S.C. 552a(j)(2)) and from 

the same requirements as in the source 

system. The requirements from which 

records described in 5 U.S.C. 552a(j)(2) 

are eligible to be exempted are: (c)(3)– 

(4); (d)(1)–(4); (e)(1)–(3), (e)(4)(G)–(I), 

(e)(5), (e)(8), (e)(12); (f); (g); and (h). 

• All other law enforcement 

investigatory material in System No. 09– 

90–1701 will be exempt, based on 5 

U.S.C. 552a(k)(2), from the requirements 

in subsections (c)(3), (d)(1)–(4), (e)(1), 

(e)(4)(G)–(I), and (f) of the Act. However, 

if any individual is denied a right, 

privilege, or benefit to which the 

individual would otherwise be entitled 

by Federal law or for which the 

individual would otherwise be eligible, 

access will be granted, except to the 

extent that the disclosure would reveal 

the identity of a source who furnished 

information to the Government under an 

express promise of confidentiality. 

• Information in this system of 

records that is classified in the interest 

of national security will be exempt, 

based on 5 U.S.C. 552a(k)(1), from the 

requirements in subsections (c)(3), 

(d)(1)–(4), (e)(1), (e)(4)(G)–(I), and (f) of 

the Act. 

HISTORY: 

None. 

Dated: June 29, 2018. 

Michael Schmoyer, 

Assistant Deputy Secretary for National 

Security. 

[FR Doc. 2018–18290 Filed 8–22–18; 8:45 am] 

BILLING CODE 4151–17–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Aspirin and 

Aging. 

Date: October 11, 2018. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, Suite 2W200, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, National Institute 

on Aging, National Institutes of Health, 

Gateway Building, Suite 2W200, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

301–402–1622, bissonettegb@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 17, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18174 Filed 8–22–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel 

Shared Instruments: NMR Spectrometers and 

X-ray Crystallography Equipment. 

Date: September 20–21, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: David R Jollie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892, (301)–435– 

1722, jollieda@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


daltland on DSKBBV9HB2PROD with NOTICES